Drug Trial News

RSS

Lower frequency deep brain stimulation effective treatment for dystonia

A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.

25 Oct 2007

Infliximab scheduled treatment has proven to be an effective strategy in IBD patients

Crohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients.

25 Oct 2007

Diffusion tensor imaging shows structural changes in mild traumatic brain injury

Researchers report that diffusion tensor imaging can identify structural changes in the white matter of the brain that correlates to cognitive deficits even in patients with mild traumatic brain injury.

25 Oct 2007

HIV patients are actually sicker when they begin therapy

It was hoped that as HIV treatment improved and as HIV-related public health initiatives encouraged people to be tested for the disease and seek care, that HIV-infected patients would seek care quickly.

25 Oct 2007

Valsartan might help prevent Alzheimer's disease

Alzheimer disease (AD), a neurodegenerative disease that is the most common form of dementia, is characterized by the formation in the brain of plaques containing misfolded beta-amyloid protein.

25 Oct 2007

Human decision-making linked to an individuals' need to maintain a homeostatic balance

A researcher at the University of California, San Diego (UCSD) School of Medicine suggests that psychiatrists may need to approach the treatment of psychiatric patients from a new direction - by understanding that such individuals' behavior and decision-making are based on an attempt to reach an inner equilibrium.

25 Oct 2007

Low-density lipoprotein may contribute to vascular diseases

Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports.

25 Oct 2007

Why do some people solve problems more creatively than others?

Are people who think creatively different from those who tend to think in a more methodical fashion?

25 Oct 2007

Test gives insight into prognosis in patients with plasma cell malignancies

A new Mayo Clinic study due to be presented at the annual meeting of the American Society of Human Genetics in San Diego this week shows that a chromosome test called “FISH” is better than conventional methods in identifying chromosomal genetic abnormalities associated with plasma cell malignancies.

24 Oct 2007

Optimism - how the brain generates the human tendency

A neural network that may generate the human tendency to be optimistic has been identified by researchers at New York University.

24 Oct 2007

Grape seed supplement studied for cardiovascular health benefits

Could some of the natural chemicals found in plants be powerful enough to improve cardiovascular health?

24 Oct 2007

Positive results for novel anti-cancer drug ECO-4601

Researchers report positive results from a Phase I/II clinical trial of a novel anti-cancer drug which offers two modes of action.

24 Oct 2007

Nicotine reduces levodopa-induced dyskinesias

The Parkinson's Institute and Clinical Center today announced research showing that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent in models of Parkinson's disease.

24 Oct 2007

Cannabis reduces pain only within a narrow dose range

Although smoking "moderate" doses of cannabis helps reduce pain in healthy research volunteers, pain is actually increased at high doses.

24 Oct 2007

Oncolytics Biotech receives approval for UK clinical trial of of REOLYSIN

Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.

24 Oct 2007

Cognitive performance in long-term abstinent elderly alcoholics

In a new study comparing elderly abstinent alcoholics with light- or nondrinking peers, the recovering alcoholics generally demonstrated equal or superior cognitive functioning to those who were not alcoholic.

24 Oct 2007

The financial burdens of overweight and obesity among elderly Americans

What many Americans eat and how little they exercise could wind up costing them - and American taxpayers - some serious money. Moreover, the overweight and obese may lose months from their lifespans.

24 Oct 2007

Intergroup attitudes among youth addressed by leading development and social psychologists

Cross-group friendships have a positive effect on intergroup attitudes among children and adolescents, according to a new issue of the International Journal of Behavioral Development, published this month.

24 Oct 2007

Traditional perception of alcoholism and impulsive behaviour may need to be reconsidered

Impulsivity is a problem common to many different personality and psychiatric disorders, including alcoholism.

24 Oct 2007

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

24 Oct 2007